New York City-based Nanowear has received FDA clearance for SimpliECG, a "remote cardiac-monitoring undergarment". This is the first clearance for the company, which has been in talks with the FDA since 2015, according to a press release.
"This is a big milestone for our young company," Cofounder and CEO Venk Varadan said in a statement. "The FDA's decision not only positions us for commercial...
